As virtual reality technologies becomes more and more accessible, R&D team in biotech try different approaches to use it in they every-day work. In this article, authors explain how it can be used to see (and even to feel!) complex molecular 3D geometry. The exemple of the exploration of this field by Novartis with the start-up Nanome illustrates what could be drug discovery tomorrow.
Using the collaborative VR platform developed by four-year-old Nanome, scientists can “physically interact with molecules, in a world that is not restricted by space, allowing users to reach out and touch a molecule as if it were an everyday object, but unlike an everyday object, force fields can be manipulated in the virtual environment effectively bringing atomic level physics to the macroscale.”